nct02637284 bpc-157 trial A human was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched BPC-157: A Prohibited Peptide and
Description
It has been used extensively in animal studies, human cell models, and increasingly in off-label therapeutic settings, with minimal toxicity or organ stress reported
Evaluating the role of sugar substitutes in weight control: efficacy vs
doi: 10.1016/j.bbrc.2006.05.042 37 YoungGSCholerisELundFEKirklandJB
That is 4mg wasted
